Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey

Br J Clin Pharmacol. 2008 Aug;66(2):320-2. doi: 10.1111/j.1365-2125.2008.03193.x. Epub 2008 Apr 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adult
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Drug Labeling
  • Female
  • Humans
  • Immunocompromised Host / drug effects
  • Immunologic Factors / adverse effects*
  • Male
  • Middle Aged
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab